Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

NHS England

This public procurement record has 1 release in its history.

Award

21 Jan 2025 at 16:17

Award Notice
Summary of the contracting process

NHS England has completed the award phase for the NHS National Framework for Transition products, with the framework commencing on 1 February 2025. This procurement is under the "Pharmaceutical products" industry classification (CPV code 33600000) and covers various regions within the United Kingdom, including East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, and Yorkshire and the Humber. The procurement method used was an open procedure above the threshold. The framework is structured into multiple lots (CESW, LSNE, NWLN) each running from 1 February 2025 to 31 May 2026, with potential extensions up to 24 months. The total contract value is £9,867,000 GBP, and the tender period ended on 18 November 2024. Notable dates include the award date on 14 January 2025, and the framework will be managed by Medicines Procurement and Supply Chain - NHS Medicines Value & Access.

This tender offers significant opportunities for businesses involved in the pharmaceutical industry, particularly those producing Eribulin Injection, Bosutinib Tablets, and Liraglutide Injection, among other transition products. The participating suppliers include both large enterprises like Sun Pharma UK Ltd, Thornton and Ross Ltd, Zentiva Pharma UK Ltd, Biocon, and Baxter Healthcare Ltd, as well as SMEs like Dr.Reddy's Laboratories (UK) Limited. SMEs stand a good chance to compete and benefit from this framework due to its inclusion policy. Successful participation could lead to substantial business growth through consistent supply contracts across various UK regions.

How relevant is this notice?

Notice Information

Notice Title

CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

Notice Description

Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-e85a5f73-1208-4e45-a159-08011aef8a18
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/ffeee3ac-9be3-4ea0-8c54-091ab8be7d3f
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£9,867,000 £1M-£10M
Lots Value
Not specified
Awards Value
£9,867,000 £1M-£10M
Contracts Value
Not specified

Notice Dates

Publication Date
21 Jan 20251 years ago
Submission Deadline
18 Nov 2024Expired
Future Notice Date
Not specified
Award Date
14 Jan 20251 years ago
Contract Period
1 Feb 2025 - 31 May 2026 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN, CHESHIRE
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
6
Supplier Names

Baxter Healthcare Ltd

Biocon

Dr.Reddy's Laboratories (UK) Limited

Sun Pharma UK Ltd

Thornton and Ross Ltd

Zentiva Pharma UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...